Eton Pharmaceuticals Inc (NASDAQ:ETON)
| 4.17 Delayed Data As of 4:00pm ET |  -0.10 / -2.34%Today’s Change | 1.98 Today|||52-Week Range 5.81 | +47.87% Year-to-Date |
Latest ETON News | Press Releases
Today’s Trading
| Previous close | 4.27 |
| Today’s open | 4.31 |
| Day’s range | 4.13 - 4.34 |
| Volume | 12,220 |
| Average volume (3 months) | 343,404 |
| Market cap | $118.3M |
Data as of 4:00pm ET, 09/29/2023
Growth & Valuation
| Earnings growth (last year) | -362.37% |
| Earnings growth (this year) | +13.89% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -2.66% |
| P/E ratio | NM |
| Price/Sales | 3.34 |
| Price/Book | 8.94 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| CTXRCitius Pharmaceutica... | -0.00 | -0.29% |
| ---- | ||
| PRQRProQR Therapeutics N... | -0.03 | -2.26% |
| ---- |
Data as of 3:59pm ET, 09/29/2023
Financials
| Next reporting date | November 16, 2023 |
| EPS forecast (this quarter) | -$0.05 |
| Annual revenue (last year) | $21.3M |
| Annual profit (last year) | -$9.0M |
| Net profit margin | -42.45% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Deer Park, Illinois |
Forecasts
